A61K35/10

Probiotic immunomodulatory compositions

The invention discloses an immunomodulatory composition comprising non-culturable bacteria, a method of production and an article and an apparatus for its use and administration.

Compositions of bioactive fulvate fractions and uses thereof

Compositions with fulvate fractions alone or in combination with growth factors, bioactive fragmented peptides, or combinations thereof are disclosed herein. Also disclosed are methods of using said compositions for the catalyzing cellular regeneration, including the healing, treatment, or prevention of skin disorders. Also disclosed are methods for extracting, isolating, and purifying fulvate fractions for use in the manufacture of said compositions.

Compositions of bioactive fulvate fractions and uses thereof

Compositions with fulvate fractions alone or in combination with growth factors, bioactive fragmented peptides, or combinations thereof are disclosed herein. Also disclosed are methods of using said compositions for the catalyzing cellular regeneration, including the healing, treatment, or prevention of skin disorders. Also disclosed are methods for extracting, isolating, and purifying fulvate fractions for use in the manufacture of said compositions.

COMPOSITIONS FOR ATHLETIC PERFORMANCE AND METHODS OF MAKING AND USING THEREOF
20210368842 · 2021-12-02 ·

The application provides nutraceutical compositions supporting an active life style. In one embodiment, the nutraceutical composition includes a gelling component in a sufficient amount to provide a cohesive gelled product and an active component. The active component consists of a vitamin B composition, a carbohydrate composition, a stimulant composition, a mineral composition, an antioxidant composition, and an herbal composition.

COMPOSITIONS FOR MENTAL ALERTNESS AND METHODS OF MAKING AND USING THEREOF
20210369718 · 2021-12-02 ·

The application provides nutraceutical compositions supporting mental alertness. In one embodiment, the nutraceutical composition comprises an active component and a gelling component in a sufficient amount to provide a cohesive gelled product. The active component comprises a carbohydrate composition, a vitamin B composition, a caffeinated composition and an anxiolytic composition, wherein the carbohydrate composition comprises a high glycemic index (GI) sugar having a GI not less than 70.

COMPOSITIONS FOR MENTAL ALERTNESS AND METHODS OF MAKING AND USING THEREOF
20210369718 · 2021-12-02 ·

The application provides nutraceutical compositions supporting mental alertness. In one embodiment, the nutraceutical composition comprises an active component and a gelling component in a sufficient amount to provide a cohesive gelled product. The active component comprises a carbohydrate composition, a vitamin B composition, a caffeinated composition and an anxiolytic composition, wherein the carbohydrate composition comprises a high glycemic index (GI) sugar having a GI not less than 70.

Compositions and methods for treating or preventing viral infections
11065298 · 2021-07-20 ·

Compositions and methods disclosed herein may be used for treating or preventing viral infections. The compositions may be administered orally to subjects in need of preventative or therapeutic treatment and/or the compositions may be used to disinfect surfaces in order to prevent or limit the spread of disease through surface contact.

Compositions and methods for treating or preventing viral infections
11065298 · 2021-07-20 ·

Compositions and methods disclosed herein may be used for treating or preventing viral infections. The compositions may be administered orally to subjects in need of preventative or therapeutic treatment and/or the compositions may be used to disinfect surfaces in order to prevent or limit the spread of disease through surface contact.

Compositions and methods for treating or preventing viral infections
11065298 · 2021-07-20 ·

Compositions and methods disclosed herein may be used for treating or preventing viral infections. The compositions may be administered orally to subjects in need of preventative or therapeutic treatment and/or the compositions may be used to disinfect surfaces in order to prevent or limit the spread of disease through surface contact.

ANGIOTENSIN I-CONVERTING ENZYME ACTIVITY INHIBITOR
20210154228 · 2021-05-27 ·

Provided is an ACE activity inhibitor that can be integrated into easy-to-take daily food and drink. The ACE activity inhibitor of the present invention contains an amber extract wherein an extraction solvent thereof is hydrous ethanol (moisture content: 1 mass % to 60 mass %).